AI system may be able to detect dementia in a day
August 10, 2021Manufacturing and Production, Medical Communications, Research and Development
Researchers from Cambridge University and The Alan Turing Institute have developed an artificial intelligence (AI) system that can diagnose dementia …
Moderna could offer better defence against Delta variant than Pfizer
August 10, 2021Manufacturing and Production
Pfizer-BioNTech’s mRNA could be less effective than Moderna’s against the Delta variant of COVID-19. In a study of more than …
Scotland approves Merck and Pfizer’s Bavencio for bladder cancer
August 10, 2021Manufacturing and Production
Merck and Pfizer’s Bavencio (avelumab) has been approved by approved by the Scottish Medicines Consortium (SMC) for use via NHS …
Researchers develop new method to kill bacteria on medical implants
August 9, 2021Medical Communications, Research and Development, Sales and Marketing
Researchers from Chalmers University of Technology, Sweden, have developed a new method to prevent bacterial infections relating to medical implants …
‘Potential’ link between vaccines and menstruation changes
August 9, 2021Sales and Marketing
France’s health body has said changes in women’s menstrual cycles are a “potential” side effect of receiving the Moderna or …
Psoriasis treatment bimekizumab maintains high Levels of skin clearance
August 9, 2021Sales and Marketing
New two-year data has shown that bimekizumab maintained high Levels of skin clearance in patients with moderate to severe plaque …
First new adult CDK treatment in 20 years gains UK and EU approval
August 9, 2021Medical Communications, Research and Development, Sales and Marketing
AstraZeneca has announced the EU approval of Forxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, alongside a licence extension from …
FDA approves Nexviazyme as treatment for late-onset Pompe disease
August 9, 2021Sales and Marketing
The FDA has approved Nexviazyme (avalglucosidase alfa-ngpt) for the treatment of patients one year of age and older with late-onset …
Sierra Oncology to licence myelofibrosis candidate from AstraZeneca
August 6, 2021Medical Communications, Research and Development, Sales and Marketing
Under a new agreement announced on Friday, AstraZeneca will licence AZD5153, a potent and selective BRD4 BET inhibitor with a …
Gilead warns of counterfeit HIV medication being distributed in US
August 6, 2021Medical Communications
Gilead have released a statement warning of tampered and counterfeit versions of its once-daily single tablet HIV treatment regimen Biktarvy …
Libtayo Phase III Trial stopped early due to significant improvement in overall survival
August 6, 2021Medical Communications
The Phase III trial of Sanofi and Regeneron’s PD-1 inhibitor Libtayo in combination with platinum-doublet chemotherapy was stopped early due …
FDA grants Orphan Drug Designation to sotigalimab for soft tissue sarcoma
August 6, 2021Medical Communications
The FDA has granted Apexigen’s sotigalimab (APX005M) Orphan Drug Designation for the treatment of soft tissue sarcoma.Sotigalimab, Apexigen’s lead therapeutic …
Cholesterol pill could cut COVID infections by up to 70%, study finds
August 6, 2021Medical Communications, Research and Development
A licensed drug normally used to treat abnormal levels of fatty substances in the blood could reduce COVID infections by …
Fresenius launches VR training for home dialysis in Germany
August 5, 2021Fresenius has launched a virtual reality-based training programme, stay safe My Training VR, for people undergoing at home dialysis.The VR …
Study finds pressured oxygen reduces ventilator need in COVID patients
August 5, 2021Medical Communications
Treating COVID patients with acute respiratory failure with continuous positive airway pressure (CPAP) reduces the need for invasive mechanical ventilation, …
NICE and AHSN to collaborate on best evidence-based healthcare
August 5, 2021NICE and the Academic Health Science Network (AHSN) are to collaborate on best evidence-based healthcare to improve the lives of …
CMA accuses Pfizer and Flynn of overcharging the NHS
August 5, 2021Having gathered further evidence, the CMA has reached a provisional view that Pfizer and Flynn broke competition law by charging …
One in five of all UK COVID hospital admissions are aged 18-34
August 5, 2021One fifth of all UK COVID hospital admissions are now from people aged 18-34, which is four times higher than …
Tokyo COVID: Cases surge as Delta variant takes hold, hospital policy U-turn expected
August 4, 2021Medical Communications, Research and Development
Japan has warned that COVID-19 cases are surging at an ‘unprecedented pace’, hitting record highs in Tokyo amid the Olympic …
Delta surge: China reports highest rate of new COVID cases since Jan
August 4, 2021Medical Communications, Research and Development
On Wednesday China reported the highest number of new locally transmitted COVID-19 cases since January, with case numbers being driven …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
